Less Ads, More Data, More Tools Register for FREE

CORRECTION TO Q2 AND HALF YEAR RESULTS

17 Nov 2023 15:00

RNS Number : 7517T
SuperSeed Capital Limited
17 November 2023

SUPERSEED CAPITAL LIMITED

("SuperSeed Capital" or the "Company")

CORRECTION TO INTERIM RESULTS FOR Q2 AND THE HALF YEAR ENDING 30 JUNE 2023

SuperSeed Capital, a company established as a venture capital fund of funds for early-stage AI/SaaS companies, presents amended and restated results for the Q2 and the six months ending 30 June 2023.

It has come to the Company's attention that the results for Q2 and for the half year ending 30 June 2023 were misstated. SuperSeed II LP ("the Fund") issued a drawdown notice close to the end of Q2 and, owing to an error, the corresponding higher valuation of the fund was accounted for in Q2 but the associated drawdown liability was not accounted for until completion of the drawdown in the following quarter. Accordingly, in the Q2 and half year figures published on 16 August 2023, the net asset value of the Fund was overstated.

The stated net asset value per share of the Company at 30 June 2023 of 1.184 p per share was overstated by 0.063p per share. The correct figure for the net asset value of the Company as at 30 June 2023 should have been 1.121p per share representing growth in net asset value per share of 15.2% over the first half of the year and 6.6% during Q2 compared with figures of 21.7% and 12.6% respectively as stated in August.

Detailed amended and restated financial statements for Q2 and for the half year ended 30 June 2023 are set out below.

Updated Q2 Financial highlights

· NAV per share has grown by 15.2% in H1 2023 and, within this, Q2 was up by 6.6% on Q1 to £1.12.

· IRR on portfolio investments since IPO has increased to 35%.

For more information, please contact:

SuperSeed Capital Limited

+44(0) 203 405 3060

Mads Jensen, Investment Manager

VSA Capital - AQSE Corporate Adviser and Broker

+44(0) 203 005 5000

Corporate Finance: Simon Barton / Alex Cabral

About SuperSeed Capital

SuperSeed Capital invests in technology-led innovation, primarily through funds managed by SuperSeed Ventures LLP (the "Investment Manager"). The Company's principal investment to date is in SuperSeed II LP (the "Fund").

SuperSeed Capital Limited

Condensed Statement of Comprehensive Income

for the period 1 January 2023 to 30 June 2023

1 April 2023

1 January 2023

1 January 2023

1 January 2022

to

to

to

to

30 June 2023

31 March 2023

30 June 2023

30 June 2022

£

£

£

£

Income

Investment income

696

328

1,024

7

Realised gain on investments held at fair value through profit or loss

-

33,052

33,052

-

Unrealised gain on investments held at fair value through profit or loss

201,489

180,555

382,044

129,162

Other income

1

1

2

951

Total income

202,186

213,936

416,122

130,120

Expenses

Establishment costs

-

-

-

153,028

Administration fees

7,613

7,611

15,224

12,432

Audit fees

5,734

5,671

11,405

10,414

Directors' fees

4,500

4,500

9,000

9,000

Legal & professional fees

16,142

12,183

28,325

14,036

Loan interest

-

134

134

-

Regulatory fees

3,836

5,351

9,187

7,315

Sundry expenses

295

703

998

830

Total expenses

38,120

36,153

74,273

207,055

Total gain/(loss) and comprehensive income for the period

164,066

177,783

341,849

(76,935)

Basic earnings per share

0.0692

0.0868

0.1463

(0.0452)

Diluted earnings per share

0.0628

0.0698

0.1403

(0.0452)

Operating profit/(loss) excluding establishment costs for the period

164,066

177,783

341,849

76,093

Basic operating profit excl. establishment costs per share

0.0692

0.0868

0.1463

0.0447

Diluted operating profit excl. establishment costs per share

0.0628

0.0698

0.1403

0.0447

All the above items are derived from continuing operations.

SuperSeed Capital Limited

Condensed Statement of Financial Position

as at 30 June 2023

30 June 2023

31 March 2023

31 December 2022

£

£

£

Non-current assets

Investments

2,542,337

2,189,288

1,799,616

Total non-current assets

2,542,337

2,189,288

1,799,616

Current assets

Trade and other receivables

104,685

254,895

11,025

Cash and cash equivalents

20,546

64,006

235,089

Total current assets

125,231

318,901

246,114

Total assets

2,667,568

2,508,189

2,045,730

Current liabilities

Trade and other payables

11,991

16,678

21,745

Total current liabilities

11,991

16,678

21,745

Total liabilities

11,991

16,678

21,745

Net assets

2,655,577

2,491,511

2,023,985

Equity

Share capital

2,369,743

2,369,743

2,080,000

Retained earnings

285,834

121,768

(56,015)

Total equity

2,655,577

2,491,511

2,023,985

Net asset value per ordinary share

1.1206

1.0514

0.9731

SuperSeed Capital Limited

Condensed Statement of Changes in Equity

for the period 1 January 2023 to 30 June 2023

Share Capital

Retained Earnings

Total

£

£

£

Ordinary Shares issued on incorporation

1

-

1

Issue of Ordinary Shares

1,999,999

-

1,999,999

Total comprehensive loss for the period

-

(119,977)

(119,977)

Balance as at 30 June 2022

2,000,000

(119,977)

1,880,023

Share Capital

Retained Earnings

Total

£

£

£

Balance as at 1 January 2023

2,080,000

(56,015)

2,023,985

Issue of Ordinary Shares

289,743

-

289,743

Total comprehensive profit for the period

-

341,849

341,849

Balance as at 30 June 2023

2,369,743

285,834

2,655,577

SuperSeed Capital Limited

Condensed Statement of Cash Flows

for the period 1 January 2023 to 30 June 2023

1 January 2023

1 January 2023

6 October 2021

to

to

to

30 June 2023

31 March 2023

30 June 2022

£

£

Cash flows used in operating activities

Net cash flow used in operating activities

(86,750)

(43,290)

(246,423)

Cash flows used in investing activities

Net cash flow used in investing activities

(127,659)

(127,659)

(777,870)

Cash flows from financing activities

Net cash flow from financing activities

(134)

(134)

2,000,000

Net movement in cash and cash equivalents during the period

(214,543)

(171,083)

975,707

Cash and cash equivalents at the beginning of the period

235,089

235,089

-

Cash and cash equivalents at the end of the period

20,546

64,006

975,707

SuperSeed Capital Limited

Investment Analysis

for the period 1 January 2023 to 30 June 2023

30 June 2023

31 December 2022

£

£

Cost

1,899,714

1,539,035

Cumulative movement in value

642,624

260,581

Fair value

2,542,337

1,799,616

Investment fair value can be further analysed as follows:

1 January 2023

1 January 2023

6 October 2021

to

to

to

30 June 2023

31 March 2023

31 December 2022

£

£

£

Cost

Cost at beginning of the period

1,539,035

1,539,035

-

Cost of investment - settled

666,579

515,017

1,539,035

Cost of investment - sold

(305,901)

(305,901)

-

Total cost of investment

1,899,714

1,748,152

1,539,035

Fair value movement

Fair value adjustment at beginning of the period

260,581

260,581

-

Revaluation of underlying investments

382,043

156,750

260,581

SuperSeed II LP management fee and other net movements in NAV

-

23,805

-

642,624

441,136

260,581

Fair value of investments

2,542,337

2,189,288

1,799,616

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NEXGPGWAGUPWGMQ

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS